# What Dose of Zepbound Is Most Effective for Weight Loss? | Buy This GLP

Compare weight loss at 5 mg, 10 mg and 15 mg in SURMOUNT-1, and see how the Zepbound label describes maintenance doses and tolerability.

Publisher: Buy This GLP Editorial Team
Canonical: https://buythisglp.com/research/what-dose-of-zepbound-is-most-effective
Updated: 2026-11-15
Published: 2026-09-18

[← Research](https://buythisglp.com/research)

Evidence

# What Dose of Zepbound Is Most Effective for Weight Loss?

The 15 mg group lost the most weight on average in SURMOUNT-1. The FDA label lists several maintenance options based on the indication.

Editorial profile: [Carla Medina](https://buythisglp.com/authors/carla-medina)[Buy This GLP Editorial Team](https://buythisglp.com/about)September 20264 min readUpdated November 2026

SURMOUNT-1, weight lost at 72 weeks · placebo · 3.1% · 5 mg · 15.0% · 10 mg · 19.5% · 15 mg · 20.9% · The 10 mg and 15 mg groups differed by 1.4 points. · 2,539 adults with overweight or obesity, without diabetes.

**Research, not medical advice.** Buy This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://buythisglp.com/methodology) and [terms](https://buythisglp.com/terms).

## Key takeaways

-   In SURMOUNT-1, the 15 mg group had the greatest average weight loss at 72 weeks.
-   The average difference between the 10 mg and 15 mg groups was 1.4 percentage points.
-   The Zepbound label lists several maintenance doses and directs prescribers to consider response and tolerability.

In SURMOUNT-1, 15 mg produced the greatest average weight loss among the three doses studied [\[1\]](https://buythisglp.com/research/what-dose-of-zepbound-is-most-effective#ref-1). The evidence on [weight loss in the first three months](https://buythisglp.com/research/how-much-weight-can-you-lose-on-zepbound-in-3-months) covers a different point in treatment. The trial’s main results reflect 72 weeks, including dose escalation.

## What the trial measured

Researchers randomized 2,539 adults with obesity or overweight and a weight-related condition, excluding diabetes. At 72 weeks, average weight loss was 15.0% on 5 mg, 19.5% on 10 mg, 20.9% on 15 mg and 3.1% on placebo [\[1\]](https://buythisglp.com/research/what-dose-of-zepbound-is-most-effective#ref-1). The 10 mg and 15 mg group averages were 1.4 percentage points apart. That difference describes randomized groups. It does not predict the extra weight an individual would lose after moving from one dose to the other.

## How side effects affected continuation

The label pools safety data from two weight-management trials [\[2\]](https://buythisglp.com/research/what-dose-of-zepbound-is-most-effective#ref-2). The [guide to GLP-1 side effects](https://buythisglp.com/research/what-are-the-side-effects-of-a-glp1) explains the problems that can arise during treatment. Digestive side effects led to stopping treatment in 1.9% at 5 mg, 3.3% at 10 mg, 4.3% at 15 mg and 0.5% on placebo.

## How prescribers choose a maintenance dose

The label lists 5 mg, 10 mg or 15 mg once weekly for weight management [\[2\]](https://buythisglp.com/research/what-dose-of-zepbound-is-most-effective#ref-2). It lists 10 mg or 15 mg once weekly for obstructive sleep apnea. The 2.5 mg strength is for starting treatment. The label directs prescribers to consider response and tolerability as they select the maintenance dose.

## Frequently asked

Which Zepbound dose led to the most weight loss in SURMOUNT-1?

At week 72, average weight loss was 20.9% at 15 mg, 19.5% at 10 mg, 15.0% at 5 mg and 3.1% with placebo.

Is 15 mg the recommended dose for everyone?

No. The weight-management label lists 5 mg, 10 mg or 15 mg once weekly and directs prescribers to consider response and tolerability.

Are the maintenance doses the same for sleep apnea?

The label lists 10 mg or 15 mg once weekly for obstructive sleep apnea.

## Sources

1.  \[1\] Jastreboff AM, Aronne LJ, Ahmad NN, et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity New England Journal of Medicine. [PMID 35658024](https://doi.org/10.1056/NEJMoa2206038)
2.  \[2\] Eli Lilly and Company (2026). Zepbound prescribing information, sections 2.1, 2.2 and 6.1 DailyMed, U.S. National Library of Medicine. [Source](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b)

## Where to get it

### Price the injectable sellers

The desk lists every seller that publishes an injectable figure, with the advertised price struck against the one a buyer is billed.

[Open the price desk →](https://buythisglp.com/)

## More in Evidence

-   [
    
    50,678 adults with a BMI of 30 or more · Prescribed · 8.0% · Filled · 4.4% · Outlined bar runs to 10%. Medicaid had lower odds of both.
    
    ### Does Medicaid Cover Weight Loss Drugs? It Depends on Your State
    
    ](https://buythisglp.com/research/does-medicaid-cover-weight-loss-drugs)
-   [
    
    What the claim rests on · Sleep study · AHI 15 or more · Obesity · BMI 30 or more · Prescription · for sleep apnea · Part D claim · plan review · Trial thresholds shown. Your plan sets its approval requirements.
    
    ### Does Medicare Cover Zepbound for Sleep Apnea? The Diagnosis Is the Key
    
    ](https://buythisglp.com/research/does-medicare-cover-zepbound-for-sleep-apnea)
-   [
    
    Illustrative decline with a one-week half-life · Ozempic window: up to 5 days late · 100% · day 0 · 82% · day 2 · 67% · day 4 · 61% · day 5 · 50% · day 7 · A calculation from the label half-life, not a blood test.
    
    ### What Happens If You Miss a Dose of Ozempic? A Week-Long Half-Life Buys Time
    
    ](https://buythisglp.com/research/what-happens-if-you-miss-a-dose-of-ozempic)
